Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

ase 3 program as we head toward the anticipated filing of our initial NDA and MAA filings next year. As we enter 2008, we also have stronger teams in place to reach our development goals and generate future growth, both here in the U.S. and in the E.U. We will appropriately spend more in 2008 compared to 2007, which is, reflected in our expense guidance for 2008. This is consistent with our expectations and goal to ultimately deliver important, novel therapeutics to patients and physicians."

de Rosen continued, "Also, 2007 was another year of strong Vancocin performance; we achieved net product sales of $204 million, representing growth of 22 percent over that of 2006. We anticipate that our new marketing initiatives will help us garner additional growth in 2008 and beyond, potentially offsetting a slow down in the incidence rate of C. difficile infection (CDI). At ViroPharma, we take our commitment to the safety of patients with CDI very seriously. Through our efforts during the year, physicians were better educated to identify patients at high risk of disease, hospitals are better equipped to control CDI, and patients at risk of severe and complicated disease were assured of a proven safe and effective treatment. Importantly, though, our efforts in CDI are also focused on future treatment alternatives: we made progress toward a potential future treatment for disease recurrence, called NTCD, which we expect to enter the clinic this year."

Net income in the fourth quarter and twelve months ended December 31, 2007 was $20.4 million and $95.4 million, respectively, compared to net income of $18.0 million and $66.7 million for the same periods in 2006. Net income per share for the quarter ended December 31, 2007 was $0.29 per share, basic and $0.25 per share, diluted, compared to a net income of $0.26 per share, basic, and $0.25 per share, diluted, for the same period in 2006. Net income per share for the twelve months ended December 31, 2007 was $1.37 pe
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
10. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
11. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... 25, 2013 By working diligently for ... the integration of the 2012 Lamborghini Aventador into their ... latest entrant in the list of vehicles lined by ... is all set to thrill automobile lovers in the ... and spectacular looks, the 2012 Lamborghini Aventador comes with ...
(Date:5/25/2013)... May 25, 2013 According to world-renowned ... beautiful and powerful women that ever lived. Cleopatra’s legendary ... some of the most powerful men in her time. ... remedies to keep her skin glowing and fresh, from ... bees- wax, maringa oil and cyprus grass. , Cleopatra ...
(Date:5/25/2013)... For college students, few events ... they are turning to prescription stimulants like Adderall ... more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . ... that students who pick up Adderall, “just to ... developing a physical and psychological dependency. While initially ...
(Date:5/25/2013)... San Antonio, TX (PRWEB) May 25, 2013 ... health-focused anti-aging center that is unique in that ... younger, but also focuses on treating what causes ... Overseen by board-certified physician Dr. James D. Weiss, ... that manage the aging process while helping patients ...
(Date:5/24/2013)... Germantown, MD (PRWEB) May 24, 2013 A ... than half of America dreads the upcoming bathing suit season. ... costumes when the weather heats up due to weight issues ... when the mercury rises. PharmaCo Labs recommends that those ... loss pill PhenObestin 37.5 as part of an overall effort ...
Breaking Medicine News(10 mins):Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3
... , PHOENIX, Aug. 14 Arizona ... medical professionals in Arizona devoted exclusively to cancer care, began caring ... last week. Located at 1916 W. Bethany Home Road, Suite 100, ... and leading edge technology. The facility marks the second radiation ...
... HILLS, Mich., Aug. 14 Work and economy related stress is ... new independent survey conducted by American Laser Centers, the largest provider ... the respondents who took part in the survey (47 percent) currently ... , , The physical toll of ...
... , INDIANAPOLIS, Aug. 14 With new ... Stericycle ExpertRECALL has introduced a CPSIA Guide designed to help ... , , , "The new regulations ... safeguard consumers against harmful products," said Mike Rozembajgier, Director at ...
... Calif., Aug. 14 Purple Communications, Inc. (Nasdaq: PRPL ... professional interpreting for deaf, hard of hearing, and speech impaired persons, ... On August 13, 2009, the Company filed with the Securities and ... quarter ended June 30, 2009. , , Total ...
... , , , SAN ... symptoms abound, few have success rates higher than 50 percent and none ... Natu r al H e alth International ... company, announced today, its Femmenessence line has been clinically proven ...
... , , ... payment strategies enables the North American home healthcare and disease ... growth in the traditionally mature patient monitoring space. The single ... the increasing incidence of cardiovascular disease (CD) in the U.S. ...
Cached Medicine News:Health News:Arizona Oncology Opens Radiation Facility at Phoenix Baptist Hospital 2Health News:Arizona Oncology Opens Radiation Facility at Phoenix Baptist Hospital 3Health News:New Consumer Safety Regulations Impose Additional Recall Requirements on Manufacturers and Retailers 2Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 2Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 3Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 4Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 5Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 6Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 7Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 8Health News:When it Comes to Natural Remedies for Hormonal Balance, the Proof is in the Clinical Research 2Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 2Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 3Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 4
(Date:5/23/2013)... 23, 2013  The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego.  According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...
(Date:5/23/2013)... 2013  Every day, their baby stopped breathing, his collapsed ... April and Bryan Gionfriddo watched helplessly, ... "Quite a few doctors said he had a good ... April Gionfriddo , about her now 20-month-old son, Kaiba. ... we would take it and run with it." ...
(Date:5/23/2013)... BEDFORD, Mass. , May 23, 2013 /PRNewswire/ ... HOLX ), a leading developer, manufacturer and ... surgical products, with an emphasis on serving the ... first large-scale observational study in a U.S. clinical ... mammography technology (breast tomosynthesis) with conventional 2D mammography ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... 2011 International Isotopes Inc (OTC Bulletin Board: ... of the Company,s general business status, particularly, the year to ... to discuss progress of its ongoing plans for the depleted ... General Business Update. When: Wednesday, September ...
... LUTHERVILLE, Md., Sept. 12, 2011 The National ... nonprofit organization that facilitates cooperation between law enforcement, ... in the prevention and investigation of drug diversion ... to a survey by the Substance Abuse and ...
Cached Medicine Technology:International Isotopes Inc Announces Conference Call to Give an Update on the Company's General Business Status 2
IR Autoflow Single Chamber Water-Jacketed CO2 Incubator...
US Autoflow Single Chamber Stackable Water-Jacketed CO2/O2 Inc....
...
Listeria Enrichment Broth...
Medicine Products: